Literature DB >> 2355191

Fluorescence-activated cell sorter analysis of binding by lipopolysaccharide-specific monoclonal antibodies to gram-negative bacteria.

M E Evans1, M Pollack, N J Hardegen, N L Koles, G Guelde, J K Chia.   

Abstract

Sixteen murine monoclonal antibodies (MAbs) reactive with the O-side chain, core oligosaccharide, or lipid A of Escherichia coli O111:B4 and Salmonella minnesota lipopolysaccharide (LPS) were evaluated for binding activity against wild-type and rough mutant strains using a fluorescence-activated cell sorter (FACS) and fluorescein-conjugated antiimmunoglobulin probe. O-side-chain-reactive MAbs produced immunofluorescence against homologous, smooth strains up to 500-fold higher than controls. Many core- and lipid A-reactive MAbs exhibited limited reactivity with smooth bacteria. Some core- and lipid A-associated epitopes, however, were better recognized by MAbs on intact bacteria than on isolated LPS. FACS analysis of binding by the core-reactive MAb, J8-4C10, to E. coli O26:B6 smooth bacteria revealed staining and non-staining bacterial phenotypes that were sorted and stably expressed in subculture. FACS analysis thus documented differences in the whole-cell reactivity of MAbs specific for various LPS subcomponents, differences in MAb reactivity with isolated and cell-associated LPS, and spontaneous changes in the phenotypic expression of certain LPS-associated epitopes on intact bacteria.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2355191     DOI: 10.1093/infdis/162.1.148

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Differential expression of Vibrio vulnificus capsular polysaccharide.

Authors:  A C Wright; J L Powell; M K Tanner; L A Ensor; A B Karpas; J G Morris; M B Sztein
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Circulating antibodies against faecal bacteria assessed by immunomorphometry: combining quantitative immunofluorescence and image analysis.

Authors:  H Z Apperloo-Renkema; M H Wilkinson; D van der Waaij
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

Review 3.  Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses.

Authors:  H M Davey; D B Kell
Journal:  Microbiol Rev       Date:  1996-12

4.  Characteristics and dynamics of bacterial populations during postantibiotic effect determined by flow cytometry.

Authors:  M Gottfredsson; H Erlendsdóttir; A Sigfússon; S Gudmundsson
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  Heterogeneity of cell-associated CP5 expression on Staphylococcus aureus strains demonstrated by flow cytometry.

Authors:  B Poutrel; P Rainard; P Sarradin
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

6.  Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria.

Authors:  S A Siegel; M E Evans; M Pollack; A O Leone; C S Kinney; S H Tam; P E Daddona
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

7.  Murine monoclonal antibodies specific for lipopolysaccharide of Escherichia coli O26 and O111.

Authors:  M Rivera-Betancourt; J E Keen
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

8.  Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; M Poppelier; K Kraaijeveld; J Verhoef
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; W Hustinx; J Schellekens; K Kraaijeveld; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Cross-reactivity of monoclonal antibodies and sera directed against lipid A and lipopolysaccharides.

Authors:  H M Kuhn
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.